Experimental models further support this association, as animals with pharmacologic or genetic inhibition of IL-1 exhibit reduced bacterial burden and bone loss, whereas transgenic overexpression of IL-1α results in periodontitis with attachment loss and alveolar bone resorption [27]. The gene discussed is IL1B; the disease is periodontitis.